vs

Side-by-side financial comparison of GCT Semiconductor Holding, Inc. (GCTS) and Galecto, Inc. (GLTO). Click either name above to swap in a different company.

Galecto, Inc. is the larger business by last-quarter revenue ($1.0M vs $758.0K, roughly 1.3× GCT Semiconductor Holding, Inc.). GCT Semiconductor Holding, Inc. runs the higher net margin — -1189.6% vs -20053.5%, a 18864.0% gap on every dollar of revenue. On growth, Galecto, Inc. posted the faster year-over-year revenue change (339.0% vs -57.5%). Over the past eight quarters, Galecto, Inc.'s revenue compounded faster (50.5% CAGR vs -58.8%).

GCT Semiconductor Holding, Inc. designs, develops and supplies high-performance wireless semiconductor solutions. Its product portfolio includes 4G LTE, 5G and IoT connectivity chips tailored for consumer electronics, industrial devices and telecom equipment. The company serves customers across North America, Asia-Pacific and European markets, with core segments covering mobile communications and edge connected devices.

Galecto Biotech is a biotechnology company that develops small molecules for the treatment of severe diseases, including fibrosis, cancer and inflammation. The company was founded in 2011 by leading galectin scientists and biotech executives from Sweden, United Kingdom, and Denmark. The company today is incorporated in the U.S., and has its operating headquarters in Copenhagen, Denmark.

GCTS vs GLTO — Head-to-Head

Bigger by revenue
GLTO
GLTO
1.3× larger
GLTO
$1.0M
$758.0K
GCTS
Growing faster (revenue YoY)
GLTO
GLTO
+396.6% gap
GLTO
339.0%
-57.5%
GCTS
Higher net margin
GCTS
GCTS
18864.0% more per $
GCTS
-1189.6%
-20053.5%
GLTO
Faster 2-yr revenue CAGR
GLTO
GLTO
Annualised
GLTO
50.5%
-58.8%
GCTS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GCTS
GCTS
GLTO
GLTO
Revenue
$758.0K
$1.0M
Net Profit
$-9.0M
$-200.7M
Gross Margin
-162.7%
Operating Margin
-1577.0%
-20149.5%
Net Margin
-1189.6%
-20053.5%
Revenue YoY
-57.5%
339.0%
Net Profit YoY
-81.4%
-2877.8%
EPS (diluted)
$-0.16
$10.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GCTS
GCTS
GLTO
GLTO
Q4 25
$758.0K
$1.0M
Q2 25
$1.2M
Q4 24
$1.8M
$228.0K
Q3 24
$2.6M
$146.0K
Q2 24
$1.5M
$213.0K
Q1 24
$3.3M
$257.0K
Q4 23
$4.2M
$340.0K
Q3 23
$4.5M
$473.0K
Net Profit
GCTS
GCTS
GLTO
GLTO
Q4 25
$-9.0M
$-200.7M
Q2 25
$-13.5M
Q4 24
$-5.0M
$-6.7M
Q3 24
$-7.1M
$-3.9M
Q2 24
$-1.0M
$-5.3M
Q1 24
$757.0K
$-5.5M
Q4 23
$-10.2M
$-6.5M
Q3 23
$-4.3M
$-8.1M
Gross Margin
GCTS
GCTS
GLTO
GLTO
Q4 25
-162.7%
Q2 25
32.0%
Q4 24
32.3%
Q3 24
62.3%
Q2 24
62.7%
Q1 24
59.8%
Q4 23
44.3%
Q3 23
11.8%
Operating Margin
GCTS
GCTS
GLTO
GLTO
Q4 25
-1577.0%
-20149.5%
Q2 25
-642.3%
Q4 24
-412.7%
-3114.9%
Q3 24
-226.5%
-2630.1%
Q2 24
-482.2%
-2618.3%
Q1 24
-2233.9%
Q4 23
-102.9%
-1962.1%
Q3 23
-89.7%
-1814.6%
Net Margin
GCTS
GCTS
GLTO
GLTO
Q4 25
-1189.6%
-20053.5%
Q2 25
-1145.3%
Q4 24
-278.5%
-2956.6%
Q3 24
-272.8%
-2659.6%
Q2 24
-71.0%
-2506.1%
Q1 24
23.2%
-2131.1%
Q4 23
-242.6%
-1904.4%
Q3 23
-97.1%
-1720.1%
EPS (diluted)
GCTS
GCTS
GLTO
GLTO
Q4 25
$-0.16
$10.86
Q2 25
$-0.26
Q4 24
$-0.15
$-5.17
Q3 24
$-0.16
$-3.39
Q2 24
$-0.02
$-4.92
Q1 24
$0.03
$-5.05
Q4 23
$-0.43
$-27.66
Q3 23
$-0.18
$-7.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GCTS
GCTS
GLTO
GLTO
Cash + ST InvestmentsLiquidity on hand
$590.0K
$257.6M
Total DebtLower is stronger
$62.6M
Stockholders' EquityBook value
$-83.3M
$240.4M
Total Assets
$15.6M
$260.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GCTS
GCTS
GLTO
GLTO
Q4 25
$590.0K
$257.6M
Q2 25
$1.3M
Q4 24
$1.4M
$14.2M
Q3 24
$1.8M
$19.7M
Q2 24
$4.0M
Q1 24
$16.1M
$27.2M
Q4 23
$258.0K
$33.2M
Q3 23
$212.9K
$44.2M
Total Debt
GCTS
GCTS
GLTO
GLTO
Q4 25
$62.6M
Q2 25
$51.7M
Q4 24
$42.6M
Q3 24
$41.8M
Q2 24
$43.6M
Q1 24
$50.5M
Q4 23
$79.9M
Q3 23
Stockholders' Equity
GCTS
GCTS
GLTO
GLTO
Q4 25
$-83.3M
$240.4M
Q2 25
$-70.0M
Q4 24
$-59.3M
$15.8M
Q3 24
$-58.3M
$20.9M
Q2 24
$-58.3M
$23.6M
Q1 24
$-62.4M
$28.2M
Q4 23
$-115.4M
$32.3M
Q3 23
$-105.7M
$37.4M
Total Assets
GCTS
GCTS
GLTO
GLTO
Q4 25
$15.6M
$260.5M
Q2 25
$17.6M
Q4 24
$19.9M
$17.1M
Q3 24
$22.6M
$23.4M
Q2 24
$23.4M
Q1 24
$35.8M
$32.5M
Q4 23
$16.4M
$38.2M
Q3 23
$43.4M
$50.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GCTS
GCTS
GLTO
GLTO
Operating Cash FlowLast quarter
$-7.2M
$566.0K
Free Cash FlowOCF − Capex
$-8.5M
FCF MarginFCF / Revenue
-1120.2%
Capex IntensityCapex / Revenue
167.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GCTS
GCTS
GLTO
GLTO
Q4 25
$-7.2M
$566.0K
Q2 25
$-8.6M
Q4 24
$-2.3M
$-4.9M
Q3 24
$-4.6M
$-3.7M
Q2 24
$-9.6M
$-4.1M
Q1 24
$-14.4M
$-5.9M
Q4 23
$-907.0K
$-11.5M
Q3 23
$-1.5M
$-8.5M
Free Cash Flow
GCTS
GCTS
GLTO
GLTO
Q4 25
$-8.5M
Q2 25
$-8.7M
Q4 24
Q3 24
$-4.7M
Q2 24
Q1 24
Q4 23
$-954.0K
Q3 23
$-1.6M
FCF Margin
GCTS
GCTS
GLTO
GLTO
Q4 25
-1120.2%
Q2 25
-738.5%
Q4 24
Q3 24
-179.3%
Q2 24
Q1 24
Q4 23
-22.8%
Q3 23
-36.0%
Capex Intensity
GCTS
GCTS
GLTO
GLTO
Q4 25
167.3%
Q2 25
7.7%
Q4 24
Q3 24
2.1%
Q2 24
Q1 24
Q4 23
1.1%
Q3 23
1.4%
Cash Conversion
GCTS
GCTS
GLTO
GLTO
Q4 25
Q2 25
Q4 24
Q3 24
Q2 24
Q1 24
-19.04×
Q4 23
Q3 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons